Table 4.
All | Female | Male | White | Black | Non-Hispanic | Hispanic | |
Number of patients, n | 166 | 83 | 73 | 117 | 40 | 140 | 17 |
First bleeding site, n (%) | |||||||
Subcutaneous | 45 (27.1%) | 25 (30.1%) | 15 (20.5%) | 34 (29.1%) | 5 (12.5%) | 37 (26.4%) | 2 (11.8%) |
Extremity NOS | 12 (7.2%) | 4 (4.8%) | 8 (11.0%) | 9 (7.7%) | 2 (5.0%) | 9 (6.4%) | 2 (11.8%) |
Subcutaneous + extremity NOS | 57 (34.3%) | 29 (34.9%) | 23 (31.5%) | 43 (36.8%) | 7 (17.5%) | 46 (32.8%) | 4 (23.6%) |
Mucosal | 35 (21.1%) | 17 (20.5%) | 17 (23.3%) | 24 (20.5%) | 10 (25.0%) | 29 (20.7%) | 5 (29.4%) |
Muscle | 9 (5.4%) | 2 (2.4%) | 5 (6.8%) | 8 (6.8%) | 1 (2.5%) | 7 (5.0%) | 2 (11.8%) |
Joint | 7 (4.2%) | 3 (3.6%) | 4 (5.5%) | 5 (4.3%) | 2 (5.0%) | 7 (5.0%) | 0 (0.0%) |
Retroperitoneal | 4 (2.4%) | 2 (2.4%) | 1 (1.4%) | 3 (2.6%) | 1 (2.5%) | 4 (2.9%) | 0 (0.0%) |
Surgery/biopsy/IV-PICC site | 3 (1.8%) | 0 (0.0%) | 3 (4.1%) | 2 (1.7%) | 1 (2.5%) | 3 (2.1%) | 0 (0.0%) |
Postpartum | 3 (1.8%) | 3 (3.6%) | NA | 3 (2.6%) | 0 (0.0%) | 3 (2.1%) | 0 (0.0%) |
Head | 3 (1.8%) | 3 (3.6%) | 0 (0.0%) | 3 (2.6%) | 0 (0.0%) | 2 (1.4%) | 1 (5.9%) |
Other | 7 (4.2%) | 6 (7.2%) | 1 (1.4%) | 3 (2.6%) | 4 (10.0%) | 7 (5.0%) | 0 (0.0%) |
Not specified | 27 (16.3%) | 27 (32.5%) | 20 (27.4%) | 29 (24.8%) | 18 (45.0%) | 41 (29.3%) | 6 (35.3%) |
IV-PICC, intravenous peripherally inserted central catheters; NA, not applicable; NOS, not otherwise specified.